Hepatitis C virus infection is blocked by HMGB1 released from virus-infected cells

Journal of Virology

Volumn 85, Issue 18, 2011, Pages 9359-9368

  Jung, Jong Ha ^a   Park, Ji Hoon ^a   Jee, Min Hyeok ^a   Keum, Sun Ju ^a   Cho, Min Sun ^b   Yoon, Seung Kew ^c   Jang, Sung Key ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; PROTEIN ANTIBODY;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CELL NUCLEUS; COMORBIDITY; CONTROLLED STUDY; CYTOPLASM; DISEASE ACTIVITY; DISEASE ASSOCIATION; EXTRACELLULAR SPACE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TRANSPORT; VIRUS INFECTIVITY; VIRUS INHIBITION;

CELL LINE; CELL NUCLEUS; CYTOPLASM; HEPACIVIRUS; HEPATITIS VIRUSES; HMGB1 PROTEIN; HUMANS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 80052489035     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00682-11     Document Type: Article

References (42)

1. Andersson, U., H. Erlandsson-Harris, H. Yang, and K. J. Tracey. 2002. HMGB1 as a DNA-binding cytokine. J. Leukoc. Biol. 72:1084-1091.
2. Andersson, U., and K. J. Tracey. 2010. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29:139-162.
3. Barqasho, B., P. Nowak, S. Abdurahman, L. Walther-Jallow, and A. Sonnerborg. 2010. Implications of the release of high-mobility group box 1 protein from dying cells during human immunodeficiency virus type 1 infection in vitro. J. Gen. Virol. 91:1800-1809.
4. Bertoletti, A., and C. Ferrari. 2003. Kinetics of the immune response during HBV and HCV infection. Hepatology 38:4-13.
5. Bianchi, M. E. 2009. HMGB1 loves company. J. Leukoc. Biol. 86:573-576.
6. Borde, C., et al. 2011. Stepwise release of biologically active HMGB1 during HSV-2 infection. PLoS One 6:e16145.
7. Chen, L. C., T. M. Yeh, H. N. Wu, Y. Y. Lin, and H. W. Shyu. 2008. Dengue virus infection induces passive release of high mobility group box 1 protein by epithelial cells. J. Infect. 56:143-150.
8. Cheng, B. Q., et al. 2008. Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma. Dig. Liver Dis. 40:446-452.
9. Choi, J., and J. H. Ou. 2006. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G847-G851.
10. Chu, J. J., and M. L. Ng. 2003. The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. J. Gen. Virol. 84:3305-3314.
11. Diamond, D. L., et al. 2010. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog. 6:e1000719.
12. Dreux, M., P. Gastaminza, S. F. Wieland, and F. V. Chisari. 2009. The autophagy machinery is required to initiate hepatitis C virus replication. Proc. Natl. Acad. Sci. U. S. A. 106:14046-14051.
13. Festi, D., et al. 2004. Safety of interferon beta treatment for chronic HCV hepatitis. World J. Gastroenterol. 10:12-16.
14. Fisher, C. L., and G. K. Pei. 1997. Modification of a PCR-based site-directed mutagenesis method. Biotechniques 23:570-574.
15. Gong, G., G. Waris, R. Tanveer, and A. Siddiqui. 2001. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl. Acad. Sci. U. S. A. 98:9599-9604.
16. Gremion, C., and A. Cerny. 2005. Hepatitis C virus and the immune system: a concise review. Rev. Med. Virol. 15:235-268.
17. Hoofnagle, J. H. 2002. Course and outcome of hepatitis C. Hepatology 36:S21-S29.
18. Huang, H., et al. 2007. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology 46:297-306.
19. Ilmakunnas, M., et al. 2008. High mobility group box 1 protein as a marker of hepatocellular injury in human liver transplantation. Liver Transpl. 14: 1517-1525.
20. Kamau, E., et al. 2009. Dengue virus infection promotes translocation of high mobility group box 1 protein from the nucleus to the cytosol in dendritic cells, upregulates cytokine production and modulates virus replication. J. Gen. Virol. 90:1827-1835.
21. Ke, P. Y., and S. S. Chen. 2010. Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro. J. Clin. Investig. 121:37-56.
22. Kim, C. S., J. H. Jung, T. Wakita, S. K. Yoon, and S. K. Jang. 2007. Monitoring the antiviral effect of alpha interferon on individual cells. J. Virol. 81:8814-8820.
23. Kim, H. J., S. Lee, and J. U. Jung. 2010. When autophagy meets viruses: a double-edged sword with functions in defense and offense. Semin. Immunopathol. 32:323-341.
24. Kim, J. H., et al. 2003. Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner. Mol. Cell. Biol. 23:708-720.
25. Korenaga, M., et al. 2005. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J. Biol. Chem. 280:37481-37488.
26. Okuda, M., et al. 2002. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122:366-375.
27. Piccoli, C., et al. 2007. Hepatitis C virus protein expression causes calciummediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress. Hepatology 46:58-65.
28. Rullier, A., et al. 2001. Immunohistochemical detection of HCV in cirrhosis, dysplastic nodules, and hepatocellular carcinomas with parallel-tissue quantitative RT-PCR. Mod. Pathol. 14:496-505.
29. Scaffidi, P., T. Misteli, and M. E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195.
30. Seeff, L. B. 2002. Natural history of chronic hepatitis C. Hepatology 36:S35-S46.
31. Seki, E., et al. 2007. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13:1324-1332.
32. Shrivastava, S., A. Raychoudhuri, R. Steele, R. Ray, and R. B. Ray. 2010. Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes. Hepatology 53:406-414.
33. Skaug, B., and Z. J. Chen. 2010. Emerging role of ISG15 in antiviral immunity. Cell 143:187-190.
34. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140:805-820.
35. Tang, D., et al. 2010. Endogenous HMGB1 regulates autophagy. J. Cell Biol. 190:881-892.
36. Tang, D., R. Kang, H. J. Zeh, and M. T. Lotze. 2010. HMGB1, oxidative stress, and disease. Antioxid. Redox Signal. 14:1315-1335.
37. Tang, D., et al. 2007. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J. Leukoc. Biol. 81:741-747.
38. Tsung, A., et al. 2007. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J. Exp. Med. 204:2913-2923.
39. Wang, H., M. F. Ward, X. G. Fan, A. E. Sama, and W. Li. 2006. Potential role of high mobility group box 1 in viral infectious diseases. Viral Immunol. 19:3-9.
40. Woodhouse, S. D., et al. 2010. Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro. Hepatology 52:443-453.
41. Yang, H., et al. 2010. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl. Acad. Sci. U. S. A. 107:11942-11947.
42. Yang, H., H. Wang, and K. J. Tracey. 2001. HMG-1 rediscovered as a cytokine. Shock 15:247-253.